3KQ6 image
Entry Detail
PDB ID:
3KQ6
Keywords:
Title:
Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural principles of a novel long-acting insulin analog
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2009-11-17
Release Date:
2010-02-23
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.25
R-Value Work:
0.19
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Insulin A chain
Mutations:E4H, T4H
Chain IDs:A, C
Chain Length:21
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Insulin B chain
Chain IDs:B, D
Chain Length:30
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation

Abstact

Bottom-up control of supramolecular protein assembly can provide a therapeutic nanobiotechnology. We demonstrate that the pharmacological properties of insulin can be enhanced by design of "zinc staples" between hexamers. Paired (i, i+4) His substitutions were introduced at an alpha-helical surface. The crystal structure contains both classical axial zinc ions and novel zinc ions at hexamer-hexamer interfaces. Although soluble at pH 4, the combined electrostatic effects of the substitutions and bridging zinc ions cause isoelectric precipitation at neutral pH. Following subcutaneous injection in a diabetic rat, the analog effected glycemic control with a time course similar to that of long acting formulation Lantus. Relative to Lantus, however, the analog discriminates at least 30-fold more stringently between the insulin receptor and mitogenic insulin-like growth factor receptor. Because aberrant mitogenic signaling may be associated with elevated cancer risk, such enhanced specificity may improve safety. Zinc stapling provides a general strategy to modify the pharmacokinetic and biological properties of a subcutaneous protein depot.

Legend

Protein

Chemical

Disease

Primary Citation of related structures